MajesTEC-7

A Study to Compare Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) in Participants With Newly Diagnosed Multiple Myeloma (MajesTEC-7)

Near Add Your Location

Sorting 50 by

Memorial Sloan Kettering Cancer Center
New York, NY
Fully Open
  • Accepting patients
  • Show Principal Investigator
City of Hope Comprehensive Cancer Center
Beckman Research Institute
Duarte, CA
  • Accepting patients
Mercy Health Cancer and Hematology Centers of West Michigan
Lacks Cancer Center
Grand Rapids, MI
  • Accepting patients
University of Nebraska Medical Center
Fred & Pamela Buffett Cancer Center
Omaha, NE
  • Accepting patients
Norton Cancer Institute (St. Matthews)
St. Matthews Campus
Louisville, KY
  • Accepting patients

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 850-0650

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.